These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31691277)

  • 1. Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis.
    Liu D; Zhang C; Wu L; Zhang L; Zhang L
    Int J Gynaecol Obstet; 2020 Jan; 148(1):6-13. PubMed ID: 31691277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
    Bérard A; Sheehy O; Zhao JP; Gorgui J; Bernatsky S; de Moura CS; Abrahamowicz M
    CMAJ; 2019 Feb; 191(7):E179-E187. PubMed ID: 30782643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.
    Mølgaard-Nielsen D; Svanström H; Melbye M; Hviid A; Pasternak B
    JAMA; 2016 Jan; 315(1):58-67. PubMed ID: 26746458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal use of fluconazole and congenital malformations in the progeny: A meta-analysis of the literature.
    Budani MC; Fensore S; Di Marzio M; Tiboni GM
    Reprod Toxicol; 2021 Mar; 100():42-51. PubMed ID: 33383164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis.
    Zhang Z; Zhang X; Zhou YY; Jiang CM; Jiang HY
    BJOG; 2019 Dec; 126(13):1546-1552. PubMed ID: 31446677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
    Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
    Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy.
    De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M
    Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral fluconazole during pregnancy and the risk of birth defects.
    Mølgaard-Nielsen D; Pasternak B; Hviid A
    N Engl J Med; 2013 Aug; 369(9):830-9. PubMed ID: 23984730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes after maternal exposure to fluconazole.
    Jick SS
    Pharmacotherapy; 1999 Feb; 19(2):221-2. PubMed ID: 10030772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks Associated With Smallpox Vaccination in Pregnancy: A Systematic Review and Meta-analysis.
    Badell ML; Meaney-Delman D; Tuuli MG; Rasmussen SA; Petersen BW; Sheffield JS; Beigi RH; Damon IK; Jamieson DJ
    Obstet Gynecol; 2015 Jun; 125(6):1439-1451. PubMed ID: 26000516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.
    Zhu Y; Bateman BT; Gray KJ; Hernandez-Diaz S; Mogun H; Straub L; Huybrechts KF
    BMJ; 2020 May; 369():m1494. PubMed ID: 32434758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity between voriconazole, fluconazole and itraconazole.
    Benjamin Lash D; Jolliff J; Munoz A; Heidari A
    J Clin Pharm Ther; 2016 Oct; 41(5):566-7. PubMed ID: 27430151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PURLs: Yeast infection in pregnancy? Think twice about fluconazole.
    Barzin A; Mounsey A
    J Fam Pract; 2016 Sep; 65(9):624-6. PubMed ID: 27672689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.
    Pasternak B; Wintzell V; Furu K; Engeland A; Neovius M; Stephansson O
    JAMA; 2018 Jun; 319(22):2333-2335. PubMed ID: 29896619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antifungal is associated with increased risk of miscarriage.
    Wise J
    BMJ; 2016 Jan; 352():h7029. PubMed ID: 26744467
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis.
    Leonardi-Bee J; Britton J; Venn A
    Pediatrics; 2011 Apr; 127(4):734-41. PubMed ID: 21382949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions of the new oral antifungal agents--terbinafine, fluconazole, and itraconazole.
    Amichai B; Grunwald MH
    Int J Dermatol; 1998 Jun; 37(6):410-5. PubMed ID: 9646122
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.